(Press-News.org) GALVESTON, Texas — A universal influenza vaccine targeting a protein common to all strains of influenza A has safely produced an immune response in humans. If proven effective, the vaccine could eliminate the practice of creating a new flu vaccine annually to match predicted strains, with major implications for global health.
The results of the clinical trials, led by the University of Texas Medical Branch at Galveston in collaboration with biotechnology company VaxInnate and funded by $9.5 million grant from the Bill and Melinda Gates Foundation, were published today online in the journal Vaccine.
The vaccine candidate, VAX102, targets a protein known as M2e, found on the surface of the influenza A virus, that has remained relatively unchanged over the last century. VAX102 consists of 4 copies of M2e fused to the protein flagellin, a TLR5 ligand used as an adjuvant. The M2e antigen had been completely unchanged from 1918 until the recent pandemic, making it of interest to researchers searching for a target for the immune response to influenza that would be stable over many seasons.
Unlike traditional flu vaccines, which target antigens that change continuously, the prototype VAX102 represents a vaccine that would not require annual updates, an important barrier to influenza prevention throughout the world. The technology used to produce the candidate vaccine would eliminate many of the limitations of current influenza vaccines, including inefficiencies related to manufacturing – such as limited production capability and the inability to change the target antigen should the vaccine not match the circulating strains.
"As we saw in the 2009 influenza pandemic, there is a great public and global health need for a rapid, scalable model for vaccine production," said lead author Christine B. Turley, M.D., Vice Chair for Clinical Services, Department of Pediatrics and a member of UTMB's Sealy Center for Vaccine Development. "If ultimately proven effective, VAX102 will meet this need and offer a completely new approach to global flu prevention and control."
Two studies, conducted at UTMB and Johnson County Clin-Trials in Lenexa, Kansas, assessed the safety, tolerability and immunogenicity – the induced immune response – of VAX102.
Healthy adults ages 18-49 were randomly assigned to receive two doses of either vaccine or placebo. The two studies established the dose range for further study. Doses ranging from 0.03 to 10 micrograms were studied. Individuals at the highest doses had more systemic reactions; doses of 1 microgram or less were safe. All vaccinated subjects showed some degree of antibody response, with a more than four-fold increase noted in all groups by 14 days after the second dose of vaccine.
An important next step will be studies to determine the degree to which the vaccine may be effective against influenza infection. Future studies would also investigate the durability of the antibody response and more closely assess cytokine responses – proteins released as part of the immune response – in an effort to better understand, predict and potentially prevent the adverse reactions noted at highest doses.
Pending results of future trials, VAX102 could be used as a stand-alone vaccine to prevent influenza A infection. Other possible strategies include use in conjunction with vaccines that target traditional influenza antigens, as a part of an approach to increase efficacy when infection occurs with mismatched strains.
VAX102 efficacy would have major global health implications, as worldwide annual influenza vaccination is not currently available due to limitations of licensed vaccines and international immunization infrastructure.
According to Turley, an influenza vaccine that can be produced rapidly and with great economies of scale, such as VAX102 through simple bacterial fermentation, allows for an entirely new approach to international influenza control. Further, because the M2e-based vaccine would not require annual updates, it could be useful to offer protection over multiple influenza seasons.
Finally, VAX102 holds promise as an improved vaccine for the elderly. "Our immune response deteriorates with age," said Turley. "Currently, the elderly aren't afforded as much protection from the flu vaccine as younger individuals. Rather than giving the elderly higher doses of a vaccine each year, VAX102 could afford long-term protection or be used as a booster strategy, maximizing immune memory."
###
ABOUT UTMB Health: Established in 1891, Texas' first academic health center comprises four health sciences schools, three institutes for advanced study, a research enterprise that includes one of only two national laboratories dedicated to the safe study of infectious threats to human health, and a health system offering a full range of primary and specialized medical services throughout Galveston County and the Texas Gulf Coast region. UTMB Health is a component of the University of Texas System and a member of the Texas Medical Center.
Universal flu vaccine clinical trials show promise
Vaccine candidate produces immune response to antigen in all strains of influenza A
2011-06-08
ELSE PRESS RELEASES FROM THIS DATE:
NASA's solar dynamics observatory catches 'surfer' waves on the sun
2011-06-08
Cue the surfing music. Scientists have spotted the iconic surfer's wave rolling through the atmosphere of the sun. This makes for more than just a nice photo-op: the waves hold clues as to how energy moves through that atmosphere, known as the corona.
Since scientists know how these kinds of waves -- initiated by a Kelvin-Helmholtz instability if you're being technical -- disperse energy in the water, they can use this information to better understand the corona. This in turn, may help solve an enduring mystery of why the corona is thousands of times hotter than originally ...
Bat Blue Supports World IPv6 Day
2011-06-08
Bat Blue Corporation, a provider of end-to-end network and security technologies and services, today announced that it will participate in World IPv6 Day on June 8th. World IPv6 Day is being organized by the Internet Society to motivate organizations to prepare their services for IPv6 to ensure a successful transition as IPv4 addresses deplete.
Bat Blue has been a proponent of IPv6 for several years and has had IPv6 enabled on its extreme-performance IP network, BlueNET, since 2008. During this time, Bat Blue has invested in many IPv6 peering relationships with other ...
NASA sees the sun having a solar blast
2011-06-08
The Sun unleashed an M-2 (medium-sized) solar flare, an S1-class (minor) radiation storm and a spectacular coronal mass ejection (CME) on June 7, 2011 from sunspot complex 1226-1227. The large cloud of particles mushroomed up and fell back down looking as if it covered an area of almost half the solar surface.
The Solar Dynamics Observatory (SDO) observed the flare's peak at 1:41a.m. ET (0641 UT). SDO recorded these images (above) in extreme ultraviolet light that show a very large eruption of cool gas. It is somewhat unique because at many places in the eruption there ...
Mortgage Rates Continue Seven Week Fall
2011-06-08
Fixed mortgage rate averages fell for a seventh consecutive week according to ForTheBestRate.com, a popular consumer mortgage rate research website. The company reports that interest rates advertised in the rate tables displayed on the site have continued to move lower over the past few weeks reaching lows not seen since the end of 2010, with current posted 30 year fixed rates as low as 4.250% (4.372% APR, Lender: Gateway Bank Mortgage).
Freddie Mac, a government sponsored enterprise that purchases residential mortgage loans in the secondary market, confirms the trend ...
The Whole Truth (and Nothing But) About Leather Furniture: American Leather Dispels Common Leather Furniture Myths
2011-06-08
If you're like most consumers, when it comes to shopping for new home furnishings, there may be some lingering doubts about what furniture is best for you and your home. And if you are like many furniture buyers, you may be unsure if leather furniture is right for your home, or even how to find the leather that best fits your decor and lifestyle.
To help consumers in this buying process, American Leather, a leading Dallas-based manufacturer of premium leather and upholstered furniture, has addressed the most common myths and misperceptions about leather furniture - and ...
Study: Stark differences in media use between minority and white youth
2011-06-08
Minority youth aged 8 to 18 consume an average of 13 hours of media content a day -- about 4-1/2 hours more than their white counterparts, according to a Northwestern University report, the first national study to focus exclusively on children's media use by race and ethnicity.
"In the past decade, the gap between minority and white youth's daily media use has doubled for blacks and quadrupled for Hispanics," says Northwestern Professor Ellen Wartella, who directed the study and heads the Center on Media and Human Development in the School of Communication. "The big question ...
Circulating levels of a lung protein found to be 'strongly predictive' of cardiovascular disease
2011-06-08
A blood protein known as surfactant protein-D (SP-D), which is mainly synthesised in the lungs, has been described as "a good predictor" of cardiovascular disease following a large study in North America. Reporting the study online today in the European Heart Journal, the investigators said that circulating SP-D levels were clearly associated with CVD and total mortality in patients with angiographically diagnosed coronary artery disease independent of other well established risk factors (such as age, smoking, cholesterol and C-reactive protein levels).(1)
In the lungs ...
Sonostics to Use New Technology to Assess Female Athletes' Risk of Knee Injury
2011-06-07
About 30 female high school athletes have been invited to participate in a free program Saturday to determine whether they are at risk of knee injury because of a muscle imbalance condition, Sonostics CEO Chuck Schwerin said.
Sonostics, a startup business spun out of Binghamton University's bioengineering department, has developed technology to measure muscle balance and will use it during the tests, to be conducted at Southern Tier Physical Therapy Associates in Vestal.
"Without our technology, no one has been able to adequately measure that balance," ...
TheAutismNewsWire Reaches 1 Year Of Providing Global Autism Awareness
2011-06-07
AutismNewsWire has set so larger goals for next year. They are now reaching about 3,000 new and unique visitors each month and would like to double that figure. Some of the bigger goals are:
1. Monthly Podcasts with Industry people and families dealing with Autism
2. Online resource books store
3. Gluten Free resource center
4. Extended family tranining and support center
5. Give aways of books to families who are having a hardship
6. Online Prayer guide
AutismNewsWire has a weekly newsletter with a large readership spanning the globe. The Vision is to ...
Yun Fitness Bootcamps now allows campers to bring kids
2011-06-07
"Lack of childcare can be a big obstacle that keeps people from committing to reach their fitness goals, especially for single parents or parents with mismatched schedules," says camp owner and head trainer Jason Yun. "We are trying to eliminate that hurdle for many of our campers and potential campers by allowing them to bring their children along with them while they work out."
Kids of campers can now accompany their parents to class, where parents will be able to keep an eye on them throughout the entire workout. Supervised childcare is not provided; ...
LAST 30 PRESS RELEASES:
Post-LLM era: New horizons for AI with knowledge, collaboration, and co-evolution
“Sloshing” from celestial collisions solves mystery of how galactic clusters stay hot
Children poisoned by the synthetic opioid, fentanyl, has risen in the U.S. – eight years of national data shows
USC researchers observe mice may have a form of first aid
VUMC to develop AI technology for therapeutic antibody discovery
Unlocking the hidden proteome: The role of coding circular RNA in cancer
Advancing lung cancer treatment: Understanding the differences between LUAD and LUSC
Study reveals widening heart disease disparities in the US
The role of ubiquitination in cancer stem cell regulation
New insights into LSD1: a key regulator in disease pathogenesis
Vanderbilt lung transplant establishes new record
Revolutionizing cancer treatment: targeting EZH2 for a new era of precision medicine
Metasurface technology offers a compact way to generate multiphoton entanglement
Effort seeks to increase cancer-gene testing in primary care
Acoustofluidics-based method facilitates intracellular nanoparticle delivery
Sulfur bacteria team up to break down organic substances in the seabed
Stretching spider silk makes it stronger
Earth's orbital rhythms link timing of giant eruptions and climate change
Ammonia build-up kills liver cells but can be prevented using existing drug
New technical guidelines pave the way for widespread adoption of methane-reducing feed additives in dairy and livestock
Eradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza
New study finds that tooth size in Otaria byronia reflects historical shifts in population abundance
nTIDE March 2025 Jobs Report: Employment rate for people with disabilities holds steady at new plateau, despite February dip
Breakthrough cardiac regeneration research offers hope for the treatment of ischemic heart failure
Fluoride in drinking water is associated with impaired childhood cognition
New composite structure boosts polypropylene’s low-temperature toughness
While most Americans strongly support civics education in schools, partisan divide on DEI policies and free speech on college campuses remains
Revolutionizing surface science: Visualization of local dielectric properties of surfaces
LearningEMS: A new framework for electric vehicle energy management
Nearly half of popular tropical plant group related to birds-of-paradise and bananas are threatened with extinction
[Press-News.org] Universal flu vaccine clinical trials show promiseVaccine candidate produces immune response to antigen in all strains of influenza A